Trembath H, Yeh J, Lopez N
Cancer Treat Res. 2024; 192:305-418.
PMID: 39212927
DOI: 10.1007/978-3-031-61238-1_15.
Cao K, Plazzer J, Macrae F
Hered Cancer Clin Pract. 2023; 21(1):27.
PMID: 38066625
PMC: 10704831.
DOI: 10.1186/s13053-023-00267-z.
Martin-Masot R, Cardelo Autero N, Ortiz Perez P, Torcuato Rubio E, Vazquez Pedreno L, Gallego Fernandez C
ACG Case Rep J. 2021; 8(8):e00646.
PMID: 34476273
PMC: 8389908.
DOI: 10.14309/crj.0000000000000646.
Lorca V, Garre P
World J Gastrointest Oncol. 2020; 11(12):1101-1114.
PMID: 31908716
PMC: 6937445.
DOI: 10.4251/wjgo.v11.i12.1101.
Ponz de Leon M, Pedroni M, Viel A, Luppi C, Conigliaro R, Domati F
Fam Cancer. 2018; 18(2):165-172.
PMID: 30196345
DOI: 10.1007/s10689-018-0100-8.
Advances in Hereditary Colorectal and Pancreatic Cancers.
Underhill M, Germansky K, Yurgelun M
Clin Ther. 2016; 38(7):1600-21.
PMID: 27045993
PMC: 5746874.
DOI: 10.1016/j.clinthera.2016.03.017.
Genetic predisposition to colorectal cancer: where we stand and future perspectives.
Valle L
World J Gastroenterol. 2014; 20(29):9828-49.
PMID: 25110415
PMC: 4123366.
DOI: 10.3748/wjg.v20.i29.9828.
The type III TGFβ receptor regulates filopodia formation via a Cdc42-mediated IRSp53-N-WASP interaction in epithelial cells.
Oh S, Knelson E, Blobe G, Mythreye K
Biochem J. 2013; 454(1):79-89.
PMID: 23750457
PMC: 4082962.
DOI: 10.1042/BJ20121701.
Identification of patients at risk for hereditary colorectal cancer.
Mishra N, Hall J
Clin Colon Rectal Surg. 2013; 25(2):67-82.
PMID: 23730221
PMC: 3423884.
DOI: 10.1055/s-0032-1313777.
Prevalence of germline PTEN, BMPR1A, SMAD4, STK11, and ENG mutations in patients with moderate-load colorectal polyps.
Ngeow J, Heald B, Rybicki L, Orloff M, Chen J, Liu X
Gastroenterology. 2013; 144(7):1402-9, 1409.e1-5.
PMID: 23399955
PMC: 3969031.
DOI: 10.1053/j.gastro.2013.02.001.
Lower gastrointestinal tract cancer predisposition syndromes.
Shah N, Lindor N
Hematol Oncol Clin North Am. 2010; 24(6):1229-52.
PMID: 21075290
PMC: 4103645.
DOI: 10.1016/j.hoc.2010.08.012.
Discovery of the BMPR1A promoter and germline mutations that cause juvenile polyposis.
Calva-Cerqueira D, Dahdaleh F, Woodfield G, Chinnathambi S, Nagy P, Larsen-Haidle J
Hum Mol Genet. 2010; 19(23):4654-62.
PMID: 20843829
PMC: 2972697.
DOI: 10.1093/hmg/ddq396.
Hereditary hamartomatous polyposis syndromes: understanding the disease risks as children reach adulthood.
Manfredi M
Gastroenterol Hepatol (N Y). 2010; 6(3):185-96.
PMID: 20567567
PMC: 2886463.
Pediatric juvenile polyposis syndromes: an update.
Huang S, Erdman S
Curr Gastroenterol Rep. 2009; 11(3):211-9.
PMID: 19463221
DOI: 10.1007/s11894-009-0033-3.
Genetics of the hamartomatous polyposis syndromes: a molecular review.
Chen H, Fang J
Int J Colorectal Dis. 2009; 24(8):865-74.
PMID: 19381654
DOI: 10.1007/s00384-009-0714-2.
Matrix metalloproteinases in the urine and tissue of patients with juvenile polyps: potential biomarkers for the presence of polyps.
Manfredi M, Fox V, Zurakowski D, Kutok J, Glickman J, Moses M
J Pediatr Gastroenterol Nutr. 2009; 48(4):405-11.
PMID: 19330927
PMC: 3715034.
DOI: 10.1097/mpg.0b013e318180e65b.
Increased cyclooxygenase-2 expression in juvenile polyposis syndrome.
van Hattem W, Brosens L, Marks S, Milne A, van Eeden S, Iacobuzio-Donahue C
Clin Gastroenterol Hepatol. 2009; 7(1):93-7.
PMID: 19124115
PMC: 2698594.
DOI: 10.1016/j.cgh.2008.07.030.
Risk of colorectal cancer in juvenile polyposis.
Brosens L, van Hattem A, Hylind L, Iacobuzio-Donahue C, Romans K, Axilbund J
Gut. 2007; 56(7):965-7.
PMID: 17303595
PMC: 1994351.
DOI: 10.1136/gut.2006.116913.
